Towards Clinical Translation of a Cell-based Therapy for Pelvic Organ Prolapse [ 2015 - 2018 ]

Research Grant

Researchers: Prof Caroline Gargett (Principal investigator) ,  A/Pr Anna Rosamilia ,  Dr Jerome Werkmeister ,  Prof John Arkwright

Brief description Pelvic organ prolapse (POP) is a hidden burden affecting 50% of all women. POP is the herniation of the uterus, bladder and/or bowel into the vagina causing incontinence and sexual dysfunction. POP results from injury to pelvic tissues during childbirth. Reconstructive surgery used to treat POP often fails. We aim to develop an innovative cell-based therapy using a woman’s own mesenchymal stem cells combined with novel scaffold materials that will regenerate the damaged pelvic tissues.

Funding Amount $AUD 1,100,689.71

Funding Scheme Project Grants

Notes Standard Project Grant